MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 30 filers reported holding MIRAGEN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $56,000 | -9.7% | 72,929 | +30.7% | 0.00% | – |
| Q2 2020 | $62,000 | +129.6% | 55,785 | -9.3% | 0.00% | – |
| Q1 2020 | $27,000 | +22.7% | 61,502 | +34.1% | 0.00% | – |
| Q4 2019 | $22,000 | -33.3% | 45,873 | 0.0% | 0.00% | – |
| Q3 2019 | $33,000 | -93.8% | 45,873 | -82.4% | 0.00% | – |
| Q2 2019 | $533,000 | -31.0% | 259,980 | -6.2% | 0.00% | – |
| Q1 2019 | $773,000 | -8.2% | 277,291 | -0.2% | 0.00% | – |
| Q4 2018 | $842,000 | -45.6% | 277,909 | +0.1% | 0.00% | – |
| Q3 2018 | $1,549,000 | -12.0% | 277,506 | +1.1% | 0.00% | – |
| Q2 2018 | $1,760,000 | +46.5% | 274,612 | +60.3% | 0.00% | – |
| Q1 2018 | $1,201,000 | -15.2% | 171,264 | +26.2% | 0.00% | – |
| Q4 2017 | $1,416,000 | +5.8% | 135,721 | -7.2% | 0.00% | – |
| Q3 2017 | $1,338,000 | -13.3% | 146,310 | +22.6% | 0.00% | – |
| Q2 2017 | $1,543,000 | – | 119,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 92,200 | $646,000 | 0.88% |
| 683 Capital Management, LLC | 500,000 | $3,505,000 | 0.31% |
| BIEGEL & WALLER LLC | 66,508 | $466,000 | 0.30% |
| Monashee Investment Management LLC | 94,000 | $659,000 | 0.18% |
| Aveo Capital Partners, LLC | 16,732 | $117,000 | 0.05% |
| Artal Group S.A. | 500,000 | $3,505,000 | 0.04% |
| Radnor Capital Management, LLC | 10,000 | $70,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 12,672 | $89,000 | 0.01% |
| Trexquant Investment LP | 15,757 | $110,000 | 0.01% |
| FMR LLC | 4,332,888 | $30,374,000 | 0.00% |